Yield10 Bioscience Inc
YTEN
Market Cap$4.2M
Close$
$-0.29
222.6% downside
Current Fair Value
222.6% downsideOvervalued by 222.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.20 Million |
|---|---|
| Enterprise Value | $4.12 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-1.82 |
| Beta | 0.75 |
| Outstanding Shares | 15,401,706 |
| Avg 30 Day Volume | 8,745,669 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.29 |
|---|---|
| PEG | 25.94 |
| Price to Sales | - |
| Price to Book Ratio | -0.24 |
| Enterprise Value to Revenue | 68.6 |
| Enterprise Value to EBIT | -0.29 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.24 |
| Debt to Equity | -0.4 |
Revenue Sources
No data
ESG Score
No data
About Yield10 Bioscience Inc
CEO: Oliver Peoples Yield10 Bioscience, Inc. is an agricultural bioscience company developing crop innovations aligned with trends in global food security, social responsibility, and sustainability. The Company is using its 'Trait Factory,' a differentiated...